{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:46:51Z","timestamp":1792788411781,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CIHR Foundation Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13643-018-0804-8","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:50:51Z","timestamp":1536684651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Antibiotic therapy for skin and soft tissue infections: a protocol for a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"7","author":[{"given":"Jessica J.","family":"Bartoszko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Mertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"issue":"2","key":"804_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1155\/2008\/846453","volume":"19","author":"V Ki","year":"2008","unstructured":"Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: a review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can J Infect Dis Med Microbiol. 2008;19(2):173\u201384.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"804_CR2","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1093\/cid\/ciu296","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10\u201352.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"804_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1473-3099(05)70191-2","volume":"5","author":"DC Vinh","year":"2005","unstructured":"Vinh DC, Embil JM. Rapidly progressive soft tissue infections. Lancet Infect Dis. 2005;5(8):501\u201313.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"804_CR4","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/jac\/dkg466","volume":"52","author":"LJ Eron","year":"2003","unstructured":"Eron LJ, Lipsky BA, Low DE, Nathwani D, Tice AD, Volturo GA. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003;52(Suppl 1):i3\u201317.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"804_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/QCO.0000000000000360","volume":"30","author":"G Poulakou","year":"2017","unstructured":"Poulakou G, Giannitsioti E, Tsiodras S. What is new in the management of skin and soft tissue infections in 2016? Curr Opin Infect Dis. 2017;30(2):158\u201371.","journal-title":"Curr Opin Infect Dis"},{"key":"804_CR6","first-page":"iii35","volume":"65 Suppl 3","author":"MS Dryden","year":"2010","unstructured":"Dryden MS. Complicated skin and soft tissue infection. J Antimicrob Chemother. 2010;65 Suppl 3:iii35\u201344.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"804_CR7","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3201\/eid1308.061575","volume":"13","author":"JK Johnson","year":"2007","unstructured":"Johnson JK, Khoie T, Shurland S, Kreisel K, Stine OC, Roghmann MC. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone. Emerg Infect Dis. 2007;13(8):1195\u2013200.","journal-title":"Emerg Infect Dis"},{"key":"804_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1471-2334-14-296","volume":"14","author":"Suaya","year":"2014","unstructured":"Suaya, et al. Incidence and cost of hospitalizations associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009. BMC Infect Dis. 2014;14:296.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"804_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1086\/651313","volume":"31","author":"AE Simor","year":"2010","unstructured":"Simor AE, Gilbert NL, Gravel D, Mulvey MR, Bryce E, Loeb M, et al. Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: National Surveillance and Changing Epidemiology, 1995\u20132007. Infect Control Hosp Epidemiol. 2010;31(4):348\u201356.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"804_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12879-015-1071-0","volume":"15","author":"LG Miller","year":"2015","unstructured":"Miller LG, Eisenberg DF, Liu H, Chang CL, Wang Y, Luthra R, et al. Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005\u20132010. BMC Infect Dis. 2015;15:362.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"804_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1017\/S1481803500011581","volume":"11","author":"H Murray","year":"2009","unstructured":"Murray H. MRSA--happy and thriving in Canada. What's an emergency doctor supposed to do? CJEM. 2009;11(5):417\u201322.","journal-title":"CJEM"},{"issue":"12","key":"804_CR12","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1128\/AAC.00649-12","volume":"56","author":"F Marra","year":"2012","unstructured":"Marra F, Patrick DM, Chong M, McKay R, Hoang L, Bowie WR. Population-based study of the increased incidence of skin and soft tissue infections and associated antimicrobial use. Antimicrob Agents Chemother. 2012;56(12):6243\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"804_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1017\/S1481803500011635","volume":"11","author":"HJ Adam","year":"2009","unstructured":"Adam HJ, Allen VG, Currie A, McGeer AJ, Simor AE, Richardson SE, et al. Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors. CJEM. 2009;11(5):439\u201346.","journal-title":"CJEM"},{"issue":"5","key":"804_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1017\/S1481803500011623","volume":"11","author":"R Stenstrom","year":"2009","unstructured":"Stenstrom R, Grafstein E, Romney M, Fahimi J, Harris D, Hunte G, et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department. CJEM. 2009;11(5):430\u20138.","journal-title":"CJEM"},{"issue":"3","key":"804_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2310\/8000.2013.130798","volume":"15","author":"B Borgundvaag","year":"2013","unstructured":"Borgundvaag B, Ng W, Rowe B, Katz K. Prevalence of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections in patients presenting to Canadian emergency departments. CJEM. 2013;15(3):141\u201360.","journal-title":"CJEM"},{"key":"804_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0920-9964(98)00126-1","volume":"35","author":"DL Streiner","year":"1999","unstructured":"Streiner DL. Placebo-controlled trials: when are they needed? Schizophr Res. 1999;35:201\u201310.","journal-title":"Schizophr Res"},{"key":"804_CR17","unstructured":"Mills, et al. Chapter 24: network meta-analysis. In: Guyatt G, Rennie D, Meade M, Cook D, editors. Users\u2019 guides to the medical literature: a manual for evidence based clinical practice 3rd edition. United States of America: McGraw-Hill Education. 2015. p. 491\u2013505."},{"issue":"6","key":"804_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ijantimicag.2012.08.004","volume":"40","author":"M Bally","year":"2012","unstructured":"Bally M, Dendukuri N, Sinclair A, Ahern SP, Poisson M, Brophy J. A network meta-analysis of antibiotics for treatment of hospitalised patients with suspected or proven meticillin-resistant Staphylococcus aureus infection. Int J Antimicrob Agents. 2012;40(6):479\u201395.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"804_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12879-016-2100-3","volume":"17","author":"R McCool","year":"2017","unstructured":"McCool R, Gould IM, Eales J, Barata T, Arber M, Fleetwood K, et al. Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA. BMC Infect Dis. 2017;17(1):39.","journal-title":"BMC Infect Dis"},{"key":"804_CR20","doi-asserted-by":"crossref","unstructured":"Agarwal R, Bartsch SM, Kelly BJ, Prewitt M, Liu Y, Chen Y, et al. Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis. Clin Microbiol Infect. 2018;24(4):361\u201368.","DOI":"10.1016\/j.cmi.2017.08.028"},{"issue":"11","key":"804_CR21","doi-asserted-by":"publisher","first-page":"e0187792","DOI":"10.1371\/journal.pone.0187792","volume":"12","author":"JF Guest","year":"2017","unstructured":"Guest JF, Esteban J, Manganelli AG, Novelli A, Rizzardini G, Serra M. Comparative efficacy and safety of antibiotics used to treat acute bacterial skin and skin structure infections: results of a network meta-analysis. PLoS One. 2017;12(11):e0187792.","journal-title":"PLoS One"},{"key":"804_CR22","unstructured":"Centre for Reviews and Dissemination. University of York. PROSPERO. International prospective register of systematic reviews. 2017. \n                    http:\/\/www.crd.york.ac.uk\/PROSPERO\/"},{"key":"804_CR23","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"issue":"11","key":"804_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, et al. The prisma extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"key":"804_CR25","unstructured":"Search filters for MEDLINE in Ovid Syntax and the PubMed translation \n                    http:\/\/hiru.mcmaster.ca\/hiru\/HIRU_Hedges_MEDLINE_Strategies.aspx\n                    \n                  . Accessed 15 Dec 2017."},{"key":"804_CR26","unstructured":"Guidance for industry acute bacterial skin and skin structure infections: developing drugs for treatment \n                    https:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm071185.pdf\n                    \n                  . Accessed 15 Dec 2017."},{"key":"804_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"key":"804_CR28","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"43","author":"Higgins","year":"2011","unstructured":"Higgins, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomized trials. BMG. 2011;43:d5928.","journal-title":"BMG"},{"key":"804_CR29","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG. Chapter 8: assessing risk of bias in included studies. In: JPT H, Green S, editors. Cochrane handbook for systematic reviews of interventions. Chichester: John Wiley & Sons; 2011."},{"key":"804_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334. 1997-09-13 07:00:00","journal-title":"BMJ"},{"issue":"7521","key":"804_CR31","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","volume":"331","author":"DM Caldwell","year":"2005","unstructured":"Caldwell DM, Ades AE, Higgins JPT. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005;331(7521):897\u2013900.","journal-title":"BMJ"},{"issue":"2","key":"804_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.7326\/0003-4819-159-2-201307160-00008","volume":"159","author":"A Cipriani","year":"2013","unstructured":"Cipriani A, Higgins JT, Geddes JR, Salanti G. Conceptual and technical challenges in network meta-analysis. Ann Intern Med. 2013;159(2):130\u20137.","journal-title":"Ann Intern Med"},{"issue":"3","key":"804_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"1","key":"804_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","volume":"172","author":"JP Higgins","year":"2009","unstructured":"Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172(1):137\u201359.","journal-title":"J R Stat Soc Ser A Stat Soc"},{"issue":"5","key":"804_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/0272989X12455847","volume":"33","author":"S Dias","year":"2013","unstructured":"Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE. Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Mak. 2013;33(5):641\u201356.","journal-title":"Med Decis Mak"},{"issue":"4","key":"804_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/jrsm.1054","volume":"3","author":"G van Valkenhoef","year":"2012","unstructured":"van Valkenhoef G, Lu G, de Brock B, Hillege H, Ades AE, Welton NJ. Automating network meta-analysis. Res Synth Methods. 2012;3(4):285\u201399.","journal-title":"Res Synth Methods"},{"key":"804_CR37","doi-asserted-by":"crossref","unstructured":"Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and network meta-analysis. BMJ. 2013;346:1\u20136.","DOI":"10.1136\/bmj.f2914"},{"key":"804_CR38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1536867X1101100206","volume":"11","author":"IR White","year":"2011","unstructured":"White IR. Multivariate random-effects meta-regression: updates to mvmeta. Stata J. 2011;11:255\u201370.","journal-title":"Stata J"},{"issue":"2","key":"804_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jrsm.1045","volume":"3","author":"IR White","year":"2012","unstructured":"White IR, Barrett JK, Jackson D, Higgins JP. Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Res Synth Methods. 2012;3(2):111\u201325.","journal-title":"Res Synth Methods"},{"key":"804_CR40","doi-asserted-by":"crossref","unstructured":"Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Stat Sci. 1992;7(4):457\u201372.","DOI":"10.1214\/ss\/1177011136"},{"issue":"20","key":"804_CR41","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1002\/sim.1875","volume":"23","author":"G Lu","year":"2004","unstructured":"Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23(20):3105\u201324.","journal-title":"Stat Med"},{"key":"804_CR42","unstructured":"National Institute for Health and Care Excellence (NICE): NICE Decision Support Unit Technical Support Documents [Internet]. \n                    https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK310366\/pdf\/Bookshelf_NBK310366.pdf\n                    \n                  . Accessed 15 Dec 2017."},{"key":"804_CR43","doi-asserted-by":"publisher","unstructured":"Med Decis Making. 2013;33(5):641\u201356. \n                    https:\/\/doi.org\/10.1177\/0272989X12455847\n                    \n                  .","DOI":"10.1177\/0272989X12455847"},{"issue":"2","key":"804_CR44","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.suc.2008.09.006","volume":"89","author":"AK May","year":"2009","unstructured":"May AK. Skin and soft tissue infections. Surg Clin North Am. 2009;89(2):403\u201320. viii","journal-title":"Surg Clin North Am"},{"issue":"5","key":"804_CR45","first-page":"143","volume":"4","author":"A Pulido-Cejudo","year":"2017","unstructured":"Pulido-Cejudo A, Guzman-Gutierrez M, Jalife-Montano A, Ortiz-Covarrubias A, Martinez-Ordaz JL, Noyola-Villalobos HF, et al. Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure. Ther Adv Infect Dis. 2017;4(5):143\u201361.","journal-title":"Ther Adv Infect Dis"},{"issue":"10","key":"804_CR46","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/497143","volume":"41","author":"DL Stevens","year":"2005","unstructured":"Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41(10):1373\u2013406.","journal-title":"Clin Infect Dis"},{"issue":"7414","key":"804_CR47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"key":"804_CR48","doi-asserted-by":"crossref","unstructured":"Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLoS One. 2013;8(10):1\u201312.","DOI":"10.1371\/journal.pone.0076654"},{"key":"804_CR49","doi-asserted-by":"crossref","unstructured":"Mbuagbaw L, Rochwerg B, Jaeschke R, Heels-Andsell D, Alhazzani W, Thabane L, et al. Approaches to interpreting and choosing the best treatments in network meta-analyses. Syst Rev. 2017;6(1):79.","DOI":"10.1186\/s13643-017-0473-z"},{"key":"804_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jclinepi.2016.02.016","volume":"76","author":"AA Veroniki","year":"2016","unstructured":"Veroniki AA, Straus SE, Fyraridis A, Tricco AC. The rank-heat plot is a novel way to present the results from a network meta-analysis including multiple outcomes. J Clin Epidemiol. 2016;76:193\u20139.","journal-title":"J Clin Epidemiol"},{"key":"804_CR51","doi-asserted-by":"publisher","first-page":"g5630","DOI":"10.1136\/bmj.g5630","volume":"349","author":"MA Puhan","year":"2014","unstructured":"Puhan MA, Schunemann HJ, Murad MH, Li T, Brignardello-Petersen R, Singh JA, et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2014;349:g5630.","journal-title":"BMJ"},{"key":"804_CR52","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.). Available from \n                    gradepro.org\n                    \n                  ."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-018-0804-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-018-0804-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-018-0804-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T19:06:41Z","timestamp":1568142401000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-018-0804-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["804"],"URL":"https:\/\/doi.org\/10.1186\/s13643-018-0804-8","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,11]]},"assertion":[{"value":"7 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DM has received funding from WHO and educational grants from Sunovion Canada. ML has received funding from CIHR and WHO, received research funding and payments for being on an advisory board from Sanofi Pasteur, research funding and an honorarium from Seqirus, and a speaking fee from Astra Zeneca. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"138"}}